Switzerland · Delayed Price · Currency is CHF Addex Therapeutics Statistics
Total Valuation
SWX:ADXN has a market cap or net worth of CHF 5.25 million. The enterprise value is 3.10 million.
| Market Cap | 5.25M |
| Enterprise Value | 3.10M |
Important Dates
The last earnings date was Monday, April 27, 2026.
| Earnings Date | Apr 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:ADXN has 116.57 million shares outstanding. The number of shares has increased by 16.24% in one year.
| Current Share Class | 116.57M |
| Shares Outstanding | 116.57M |
| Shares Change (YoY) | +16.24% |
| Shares Change (QoQ) | +28.33% |
| Owned by Insiders (%) | 19.09% |
| Owned by Institutions (%) | 2.14% |
| Float | 92.72M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 30.32 |
| PB Ratio | 0.88 |
| P/TBV Ratio | 0.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -0.46 |
| EV / Sales | 17.89 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -175.94 |
Financial Efficiency
Return on equity (ROE) is -87.53% and return on invested capital (ROIC) is -22.39%.
| Return on Equity (ROE) | -87.53% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -22.39% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 15.28% |
| Revenue Per Employee | 86,500 |
| Profits Per Employee | -3.36M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -20.13% in the last 52 weeks. The beta is 1.98, so SWX:ADXN's price volatility has been higher than the market average.
| Beta (5Y) | 1.98 |
| 52-Week Price Change | -20.13% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.05 |
| Relative Strength Index (RSI) | 52.52 |
| Average Volume (20 Days) | 225,606 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:ADXN had revenue of CHF 173,000 and -6.73 million in losses. Loss per share was -0.06.
| Revenue | 173,000 |
| Gross Profit | 173,000 |
| Operating Income | -2.82M |
| Pretax Income | -6.84M |
| Net Income | -6.73M |
| EBITDA | -2.81M |
| EBIT | -2.82M |
| Loss Per Share | -0.06 |
Balance Sheet
The company has 2.19 million in cash and 36,549 in debt, with a net cash position of 2.15 million or 0.02 per share.
| Cash & Cash Equivalents | 2.19M |
| Total Debt | 36,549 |
| Net Cash | 2.15M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 5.96M |
| Book Value Per Share | 0.05 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 424 |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -1,627.17% |
| Pretax Margin | -3,955.49% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SWX:ADXN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -16.24% |
| Shareholder Yield | -16.24% |
| Earnings Yield | -128.28% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |